BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 27630278)

  • 1. Lymphangiogenesis and Anti-lymphangiogenesis in Cutaneous Melanoma.
    Raica M; Jitariu AA; Cimpean AM
    Anticancer Res; 2016 Sep; 36(9):4427-35. PubMed ID: 27630278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor lymphangiogenesis and melanoma metastasis.
    Rinderknecht M; Detmar M
    J Cell Physiol; 2008 Aug; 216(2):347-54. PubMed ID: 18481261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphangiogenesis and its relationship with lymphatic metastasis and prognosis in malignant melanoma.
    Liu B; Ma J; Wang X; Su F; Li X; Yang S; Ma W; Zhang Y
    Anat Rec (Hoboken); 2008 Oct; 291(10):1227-35. PubMed ID: 18561194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival.
    Dadras SS; Paul T; Bertoncini J; Brown LF; Muzikansky A; Jackson DG; Ellwanger U; Garbe C; Mihm MC; Detmar M
    Am J Pathol; 2003 Jun; 162(6):1951-60. PubMed ID: 12759251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression pattern of the lymphatic and vascular markers VEGFR-3 and CD31 does not predict regional lymph node metastasis in cutaneous melanoma.
    Wobser M; Siedel C; Schrama D; Bröcker EB; Becker JC; Vetter-Kauczok CS
    Arch Dermatol Res; 2006 Feb; 297(8):352-7. PubMed ID: 16395613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor lymphangiogenesis predicts melanoma metastasis to sentinel lymph nodes.
    Dadras SS; Lange-Asschenfeldt B; Velasco P; Nguyen L; Vora A; Muzikansky A; Jahnke K; Hauschild A; Hirakawa S; Mihm MC; Detmar M
    Mod Pathol; 2005 Sep; 18(9):1232-42. PubMed ID: 15803182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular control of lymphatic metastasis.
    Achen MG; Stacker SA
    Ann N Y Acad Sci; 2008; 1131():225-34. PubMed ID: 18519975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of tumor cells and lymphatic vessels in cancer progression.
    Alitalo A; Detmar M
    Oncogene; 2012 Oct; 31(42):4499-508. PubMed ID: 22179834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumour lymphangiogenesis is a possible predictor of sentinel lymph node status in cutaneous melanoma: a case-control study.
    Massi D; Puig S; Franchi A; Malvehy J; Vidal-Sicart S; González-Cao M; Baroni G; Ketabchi S; Palou J; Santucci M
    J Clin Pathol; 2006 Feb; 59(2):166-73. PubMed ID: 16443733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From tumor lymphangiogenesis to lymphvascular niche.
    Hirakawa S
    Cancer Sci; 2009 Jun; 100(6):983-9. PubMed ID: 19385973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased Angiogenesis and Lymphangiogenesis in Metastatic Sentinel Lymph Nodes Is Associated With Nonsentinel Lymph Node Involvement and Distant Metastasis in Patients With Melanoma.
    Pastushenko I; Van den Eynden GG; Vicente-Arregui S; Prieto-Torres L; Alvarez-Alegret R; Querol I; Dirix LY; Carapeto FJ; Vermeulen PB; Van Laere SJ
    Am J Dermatopathol; 2016 May; 38(5):338-46. PubMed ID: 26909582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients.
    Liu H; Yang Y; Xiao J; Yang S; Liu Y; Kang W; Li X; Zhang F
    Microvasc Res; 2014 May; 93():1-8. PubMed ID: 24603190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intratumoral lymphatics and lymphatic vessel invasion detected by D2-40 are essential for lymph node metastasis in bladder transitional cell carcinoma.
    Ma Y; Hou Y; Liu B; Li X; Yang S; Ma J
    Anat Rec (Hoboken); 2010 Nov; 293(11):1847-54. PubMed ID: 20730866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma.
    Niakosari F; Kahn HJ; McCready D; Ghazarian D; Rotstein LE; Marks A; Kiss A; From L
    Arch Dermatol; 2008 Apr; 144(4):462-7. PubMed ID: 18427039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphangiogenesis and its correlation with the VEGF expression and the sentinel lymph node in cutaneous melanomas.
    Buzrla P; Dvorackova J; Motyka O
    Biomed Res Int; 2014; 2014():372979. PubMed ID: 25089267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphatic vessels regulate immune microenvironments in human and murine melanoma.
    Lund AW; Wagner M; Fankhauser M; Steinskog ES; Broggi MA; Spranger S; Gajewski TF; Alitalo K; Eikesdal HP; Wiig H; Swartz MA
    J Clin Invest; 2016 Sep; 126(9):3389-402. PubMed ID: 27525437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of tumor-associated lymphangiogenesis in malignant melanomas of the conjunctiva.
    Heindl LM; Hofmann-Rummelt C; Adler W; Bosch JJ; Holbach LM; Naumann GO; Kruse FE; Cursiefen C
    Ophthalmology; 2011 Dec; 118(12):2351-60. PubMed ID: 21835473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor and lymph node lymphangiogenesis--impact on cancer metastasis.
    Tobler NE; Detmar M
    J Leukoc Biol; 2006 Oct; 80(4):691-6. PubMed ID: 16793912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor metastasis and the lymphatic vasculature.
    Sleeman JP; Thiele W
    Int J Cancer; 2009 Dec; 125(12):2747-56. PubMed ID: 19569051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-induced sentinel lymph node lymphangiogenesis and increased lymph flow precede melanoma metastasis.
    Harrell MI; Iritani BM; Ruddell A
    Am J Pathol; 2007 Feb; 170(2):774-86. PubMed ID: 17255343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.